IMAX (IMAX) Financials

$27.81 -0.28 (-1.00%)

Closing price 03:59 PM Eastern

Extended Trading

$27.82 +0.01 (+0.04%)

As of 06:14 PM Eastern

Annual Income Statements for IMAX

This table shows IMAX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Income / (Loss) Attributable to Common Shareholders	26	25	-23	-22	-144	47	23	2.34	29	56	40
Consolidated Net Income / (Loss)	33	33	-20	-9.58	-157	59	34	13	39	65	42
Net Income / (Loss) Continuing Operations	33	33	-20	-9.58	-157	59	34	13	39	65	42
Total Pre-Tax Income	38	46	-9.77	11	-129	75	44	30	58	87	57
Total Operating Income	44	50	-4.83	11	-122	77	45	31	59	88	58
Total Gross Profit	190	214	156	134	2.33	212	205	185	203	219	173
Total Revenue	352	375	301	255	137	396	374	381	377	374	291
Operating Revenue	352	375	301	255	137	396	374	381	377	374	291
Total Cost of Revenue	162	160	144	117	135	184	170	196	175	155	117
Operating Cost of Revenue	162	160	144	120	116	181	166	196	175	155	117
Total Operating Expenses	146	164	161	127	125	134	160	154	144	132	116
Selling, General & Admin Expense	133	144	138	117	108	123	117	110	124	115	93
Research & Development Expense	5.10	10	5.30	6.94	5.62	5.20	14	21	16	13	16
Amortization Expense	5.76	4.58	4.83	4.88	5.39	4.96	4.15	3.02	2.08	1.86	1.72
Other Operating Expenses / (Income)	-0.97	1.76	8.55	-	-	-	2.99	2.65	0.95	0.75	0.92
Impairment Charge	0.00	0.14	4.47	0.00	1.15	0.00	0.00	1.23	0.42	0.83	3.52
Restructuring Charge	3.75	2.95	0.00	0.00	0.00	0.85	9.54	16	0.00	0.00	-
Total Other Income / (Expense), net	-6.16	-4.28	-4.94	0.00	-6.70	-1.94	-1.57	-1.43	-0.74	-0.69	-0.52
Interest Expense	8.47	7.23	6.43	7.09	7.01	3.53	2.92	1.94	2.23	1.66	0.92
Interest & Investment Income	2.31	2.95	1.50	7.56	0.31	1.59	1.84	1.03	-	-	-
Income Tax Expense	5.00	13	10	21	27	17	9.52	17	16	20	14
Net Income / (Loss) Attributable to Noncontrolling Interest	6.64	7.73	2.92	13	-14	12	11	10	11	8.78	2.43
Basic Earnings per Share	$0.49	$0.47	($0.40)	($0.38)	($2.43)	$0.76	$0.36	$0.04	$0.43	$0.79	$0.58
Weighted Average Basic Shares Outstanding	52.65M	54.31M	56.67M	59.13M	59.24M	61.36M	61.48M	58.60M	66.90M	70.70M	68.50M
Diluted Earnings per Share	$0.48	$0.46	($0.40)	($0.38)	($2.43)	$0.76	$0.36	$0.04	$0.42	$0.78	$0.56
Weighted Average Diluted Shares Outstanding	53.86M	55.15M	56.67M	59.13M	59.24M	61.36M	61.48M	58.60M	66.90M	70.70M	68.50M
Weighted Average Basic & Diluted Shares Outstanding	53.02M	52.95M	53.97M	58.58M	58.95M	61.36M	61.48M	58.60M	66.90M	70.70M	68.50M

This table shows IMAX's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	2.33	5.31	14	3.58	3.27	2.54	12	8.35	2.45	2.61	-8.95
Consolidated Net Income / (Loss)	8.15	6.87	15	5.07	5.42	3.31	15	9.61	5.12	4.08	-7.76
Net Income / (Loss) Continuing Operations	8.15	6.87	15	5.07	5.42	3.31	15	9.61	5.12	4.08	-7.76
Total Pre-Tax Income	15	8.32	18	1.08	11	1.46	22	13	10	6.10	-5.41
Total Operating Income	17	9.51	19	2.87	12	2.74	22	14	11	7.54	-4.24
Total Gross Profit	53	48	51	44	47	44	63	58	50	56	32
Total Revenue	87	93	91	89	79	86	104	98	87	98	69
Operating Revenue	87	93	91	89	79	86	104	98	87	98	69
Total Cost of Revenue	33	44	40	45	32	42	41	40	37	41	38
Operating Cost of Revenue	33	44	40	45	32	42	41	40	37	49	37
Total Operating Expenses	37	39	32	41	35	41	41	44	38	49	35
Selling, General & Admin Expense	33	32	31	38	31	35	36	39	34	38	33
Research & Development Expense	1.32	1.15	-0.27	2.03	2.19	2.72	2.77	2.76	1.86	1.63	1.12
Amortization Expense	1.73	1.55	1.54	1.32	1.34	1.25	1.11	1.15	1.07	1.42	1.11
Restructuring Charge	0.06	3.75	0.00	0.00	0.00	1.59	0.00	0.00	1.35	-	-
Total Other Income / (Expense), net	-1.30	-1.19	-1.69	-1.80	-1.49	-1.28	-0.46	-1.15	-1.39	-1.44	-1.17
Interest Expense	1.80	1.90	2.35	2.28	1.95	2.03	1.56	1.80	1.84	1.80	1.32
Interest & Investment Income	0.57	0.49	0.66	0.59	0.56	0.68	1.10	0.72	0.45	0.22	0.29
Other Income / (Expense), net	-0.07	-	-	-0.11	-0.11	-	-	-0.08	-	-	-0.14
Income Tax Expense	7.29	1.46	2.38	-4.00	5.16	-1.85	6.56	3.46	4.89	2.02	2.35
Net Income / (Loss) Attributable to Noncontrolling Interest	5.82	1.56	1.45	1.49	2.15	0.77	3.03	1.26	2.67	1.47	1.20
Basic Earnings per Share	$0.04	$0.10	$0.26	$0.07	$0.06	$0.05	$0.22	$0.15	$0.05	$0.04	($0.16)
Weighted Average Basic Shares Outstanding	53.15M	52.65M	52.68M	52.63M	52.50M	54.31M	54.62M	54.59M	54.06M	56.67M	56.04M
Diluted Earnings per Share	$0.04	$0.09	$0.26	$0.07	$0.06	$0.05	$0.22	$0.15	$0.04	$0.04	($0.16)
Weighted Average Diluted Shares Outstanding	54.97M	53.86M	54.09M	53.43M	53.41M	55.15M	55.54M	55.32M	54.99M	56.67M	56.04M
Weighted Average Basic & Diluted Shares Outstanding	53.74M	53.02M	52.68M	52.68M	52.62M	52.95M	54.61M	54.62M	54.59M	53.97M	55.97M

This table details how cash moves in and out of IMAX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Change in Cash & Equivalents	24	-21	-92	-128	208	-32	-17	-46	-113	211	77
Net Cash From Operating Activities	71	59	17	6.07	-23	90	110	85	78	84	87
Net Cash From Continuing Operating Activities	71	59	17	6.07	-23	90	110	85	122	114	125
Net Income / (Loss) Continuing Operations	33	33	-20	-9.58	-157	59	34	13	39	65	42
Consolidated Net Income / (Loss)	33	33	-20	-9.58	-157	59	34	13	39	65	42
Depreciation Expense	66	60	57	56	53	63	57	67	46	43	34
Amortization Expense	1.97	2.24	3.18	2.51	0.90	0.51	-	-	-	-	-
Non-Cash Adjustments To Reconcile Net Income	23	27	44	19	61	33	23	54	41	31	24
Changes in Operating Assets and Liabilities, net	-53	-64	-67	-62	20	-65	-3.65	-48	-49	-54	-13
Net Cash From Investing Activities	-41	-32	-53	-0.01	-9.26	-66	-57	-74	-65	-79	-62
Net Cash From Continuing Investing Activities	-41	-32	-53	-0.01	-9.26	-66	-57	-74	-65	-79	-62
Purchase of Property, Plant & Equipment	-8.43	-6.49	-8.42	-3.59	-0.70	-7.42	-13	-24	-15	-43	-40
Acquisitions	-8.45	-8.34	-20	-4.09	-1.90	-2.93	-8.70	-5.21	-6.70	-7.07	-5.42
Sale and/or Maturity of Investments	0.00	1.05	0.00	18	0.00	-15	-	-	-	-	-
Other Investing Activities, net	-24	-18	-25	-10	-6.65	-40	-35	-43	-43	-28	-17
Net Cash From Financing Activities	-6.04	-49	-59	-133	241	-57	-71	-58	-126	205	52
Net Cash From Continuing Financing Activities	-6.04	-49	-59	-133	241	-57	-71	-58	-126	205	52
Repayment of Debt	-43	-53	-5.88	-309	-1.07	-55	-53	-2.00	-20	-12	-1.22
Repurchase of Common Equity	-18	-27	-83	-24	-38	-22	-71	-46	-2.00	-51	-3.06
Payment of Dividends	0.00	-1.44	-2.70	-4.89	-4.21	-4.38	-6.93	0.00	0.00	-9.51	0.00
Issuance of Debt	55	40	38	227	288	35	65	0.00	0.00	25	4.71
Other Financing Activities, net	-0.20	-6.95	-4.64	-22	-0.51	1.81	-12	-4.26	10	33	6.98
Other Net Changes in Cash	0.81	0.50	2.17	-1.01	-0.41	-	-	-	-	-	-

This table details how cash moves in and out of IMAX's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-3.52	-3.91	13	11	4.82	-33	14	-3.98	1.85	10	-23
Net Cash From Operating Activities	6.95	11	35	35	-11	4.01	29	4.64	21	17	5.77
Net Cash From Continuing Operating Activities	6.95	11	35	35	-11	4.01	29	4.64	21	17	5.77
Net Income / (Loss) Continuing Operations	8.15	6.87	15	5.07	5.42	3.31	15	9.61	5.12	4.08	-7.76
Consolidated Net Income / (Loss)	8.15	6.87	15	5.07	5.42	3.31	15	9.61	5.12	4.08	-7.76
Depreciation Expense	15	17	15	19	15	14	19	14	13	14	16
Amortization Expense	0.49	0.49	0.49	0.49	0.49	0.49	0.49	0.63	0.63	0.71	0.71
Non-Cash Adjustments To Reconcile Net Income	5.60	4.60	4.40	9.39	4.93	7.29	5.73	8.64	5.54	9.76	7.06
Changes in Operating Assets and Liabilities, net	-22	-17	0.15	1.25	-37	-21	-12	-28	-3.39	-12	-9.88
Net Cash From Investing Activities	-15	-11	-15	-8.50	-7.14	-13	-10	-4.24	-4.28	-13	-22
Net Cash From Continuing Investing Activities	-15	-11	-15	-8.50	-7.14	-13	-10	-4.24	-4.28	-13	-22
Purchase of Property, Plant & Equipment	-1.65	-4.61	-1.13	-1.59	-1.10	-3.95	-1.53	-0.65	-0.36	-3.18	-2.31
Acquisitions	-1.23	-3.65	-1.61	-1.60	-1.59	-2.93	-1.94	-1.72	-1.76	-4.45	-14
Other Investing Activities, net	-12	-2.61	-12	-5.32	-4.44	-7.30	-6.67	-1.88	-2.16	-5.26	-5.89
Net Cash From Financing Activities	4.23	-5.09	-7.56	-16	23	-24	-4.59	-4.72	-15	6.08	-7.09
Net Cash From Continuing Financing Activities	4.23	-5.09	-7.56	-16	23	-24	-4.59	-4.72	-15	6.08	-7.09
Repayment of Debt	-10	-10	-11	-21	-0.16	-10	-4.17	-7.71	-31	-0.00	-3.85
Repurchase of Common Equity	0.00	0.13	-	-0.25	-18	-23	-0.25	-0.36	-3.66	-27	-5.43
Issuance of Debt	23	-	4.00	6.00	45	8.69	0.32	5.00	26	33	4.89
Other Financing Activities, net	-8.56	5.16	-0.38	-0.78	-4.19	-0.01	-0.48	-0.23	-6.23	-0.35	-
Other Net Changes in Cash	-0.08	-	-	-	0.13	-0.10	-	-	-0.06	0.21	0.76

This table presents IMAX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Total Assets	830	815	821	883	998	889	874	867	857	931	622
Total Current Assets	254	256	407	480	555	390	290	457	472	578	310
Cash & Equivalents	101	76	97	190	317	109	142	159	205	317	107
Accounts Receivable	108	136	136	110	56	100	93	260	218	215	182
Inventories, net	33	32	32	27	40	43	45	31	42	39	17
Prepaid Expenses	13	12	12	12	10	10	10	7.55	6.63	6.50	4.95
Plant, Property, & Equipment, net	240	243	253	260	277	307	281	277	245	218	183
Total Noncurrent Assets	336	315	161	143	165	192	303	133	140	134	128
Noncurrent Note & Lease Receivables	202	191	44	44	41	40	127	-	-	-	-
Goodwill	53	53	53	39	39	39	39	39	39	39	39
Intangible Assets	35	35	33	23	26	30	34	31	30	29	28
Noncurrent Deferred & Refundable Income Taxes	14	7.99	9.90	14	18	24	31	31	21	26	23
Other Noncurrent Operating Assets	31	28	21	22	27	43	70	32	50	41	38
Total Liabilities & Shareholders' Equity	830	815	821	883	998	889	874	867	857	931	622
Total Liabilities	452	469	491	453	533	246	274	263	231	253	195
Total Current Liabilities	173	137	143	128	208	133	130	238	203	224	190
Accounts Payable	20	26	25	16	21	20	32	24	20	23	26
Accrued Expenses	101	111	117	112	99	113	98	100	93	96	75
Current Deferred Revenue	53	-	-	-	88	-	-	113	90	105	89
Total Noncurrent Liabilities	279	332	349	325	325	113	144	25	27	29	4.71
Long-Term Debt	266	252	263	226	306	18	38	25	27	29	4.71
Noncurrent Deferred & Payable Income Tax Liabilities	13	13	15	18	19	0.00	-	-	-	-	-
Commitments & Contingencies	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	0.68	0.66	0.72	0.76	0.76	5.91	6.44	1.35	4.98	3.31	44
Total Equity & Noncontrolling Interests	378	345	329	430	464	637	593	602	622	674	383
Total Preferred & Common Equity	299	273	263	356	394	548	512	528	562	624	383
Total Common Equity	299	273	263	356	394	548	512	528	562	624	383
Common Stock	587	574	562	585	596	595	602	621	617	611	392
Retained Earnings	-275	-293	-293	-235	-203	-40	-85	-88	-47	20	-6.26
Accumulated Other Comprehensive Income / (Loss)	-17	-12	-9.85	2.53	0.99	-3.19	-3.59	-0.63	-5.20	-7.44	-3.15
Other Equity Adjustments	4.05	3.93	3.93	3.93	0.00	-	-	-	-	-	-
Noncontrolling Interest	78	72	66	74	70	89	81	75	60	50	0.00

This table presents IMAX's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	848	848	827	824	851	816	822	800
Total Current Assets	265	270	263	396	429	396	406	385
Cash & Equivalents	97	105	92	81	110	95	99	87
Accounts Receivable	122	114	122	141	136	126	123	126
Inventories, net	32	38	38	36	45	37	37	36
Prepaid Expenses	14	13	12	13	13	12	14	13
Plant, Property, & Equipment, net	245	245	238	240	238	239	248	252
Total Noncurrent Assets	338	333	327	188	184	181	168	164
Noncurrent Note & Lease Receivables	203	198	193	65	59	57	47	44
Goodwill	53	53	53	53	53	53	53	62
Intangible Assets	35	34	35	35	34	34	33	22
Noncurrent Deferred & Refundable Income Taxes	14	16	16	7.71	12	11	11	14
Other Noncurrent Operating Assets	33	32	30	28	25	24	22	21
Total Liabilities & Shareholders' Equity	848	848	827	824	851	816	822	800
Total Liabilities	464	480	484	491	494	478	488	462
Total Current Liabilities	118	191	189	120	228	141	213	142
Accounts Payable	25	26	20	19	38	24	26	23
Accrued Expenses	93	111	106	101	124	117	114	119
Total Noncurrent Liabilities	346	289	295	371	266	337	275	321
Long-Term Debt	280	276	283	297	252	256	259	229
Noncurrent Deferred Revenue	54	-	-	61	-	68	-	76
Noncurrent Deferred & Payable Income Tax Liabilities	13	13	13	13	13	14	16	15
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	0.68	0.67	0.66	0.65	0.66	0.73	0.73	0.74
Total Equity & Noncontrolling Interests	384	367	342	333	357	337	333	337
Total Preferred & Common Equity	300	289	267	259	287	271	264	273
Total Common Equity	300	289	267	259	287	271	264	273
Common Stock	584	577	571	565	570	566	560	569
Retained Earnings	-272	-280	-294	-297	-272	-284	-292	-283
Accumulated Other Comprehensive Income / (Loss)	-16	-11	-14	-13	-15	-15	-7.88	-16
Other Equity Adjustments	4.11	3.93	3.93	3.93	3.93	3.93	3.93	3.93
Noncontrolling Interest	84	78	75	74	70	66	69	64

This table displays calculated financial ratios and metrics derived from IMAX's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-6.04%	24.61%	18.02%	86.04%	-65.37%	5.68%	-1.67%	0.91%	0.94%	28.66%	0.90%
EBITDA Growth	-1.17%	104.81%	-20.42%	201.32%	-148.46%	37.85%	4.48%	-8.29%	-18.98%	42.93%	-10.06%
EBIT Growth	-12.97%	1,142.57%	-145.95%	108.64%	-257.64%	72.97%	44.46%	-48.53%	-32.29%	52.28%	-10.56%
NOPAT Growth	5.30%	1,167.90%	64.66%	88.77%	-241.94%	70.12%	154.94%	-67.16%	-37.57%	56.12%	-10.10%
Net Income Growth	-1.10%	266.35%	-107.55%	93.92%	-368.88%	74.34%	168.37%	-68.16%	-39.16%	53.25%	-4.41%
EPS Growth	4.35%	215.00%	-5.26%	84.36%	-419.74%	111.11%	800.00%	-90.48%	-46.15%	39.29%	-12.50%
Operating Cash Flow Growth	20.85%	238.40%	185.59%	126.36%	-125.46%	-17.82%	28.82%	9.62%	-7.52%	-3.11%	57.91%
Free Cash Flow Firm Growth	72.59%	128.22%	10.55%	-412.95%	-37.85%	66.57%	251.94%	59.45%	-617.39%	-58.79%	903.56%
Invested Capital Growth	4.30%	5.48%	6.16%	5.98%	-18.04%	8.42%	5.16%	4.71%	15.46%	19.73%	12.02%
Revenue Q/Q Growth	1.93%	-3.11%	-3.38%	25.99%	-33.26%	4.03%	-4.24%	5.15%	-3.19%	4.73%	-0.88%
EBITDA Q/Q Growth	9.68%	-4.63%	-26.33%	171.16%	-180.35%	23.62%	-24.17%	24.59%	-12.39%	4.93%	-7.48%
EBIT Q/Q Growth	18.26%	-8.69%	-136.45%	136.10%	-47.65%	46.03%	-31.94%	17.27%	-20.78%	5.20%	-13.52%
NOPAT Q/Q Growth	8.53%	-1.80%	79.11%	53.07%	-47.65%	76.33%	-28.70%	-20.73%	-26.04%	7.04%	-14.06%
Net Income Q/Q Growth	12.20%	-2.28%	-87.89%	77.47%	-35.08%	42.89%	-12.79%	-21.25%	-26.49%	6.13%	-11.19%
EPS Q/Q Growth	9.09%	2.22%	-48.15%	58.70%	-37.29%	52.00%	-12.20%	-55.56%	-31.15%	4.00%	-17.65%
Operating Cash Flow Q/Q Growth	11.80%	-17.96%	-33.71%	151.51%	-198.88%	-17.21%	22.17%	-11.07%	-10.99%	47.58%	-7.48%
Free Cash Flow Firm Q/Q Growth	459.80%	-41.68%	10.85%	-209.14%	23.67%	297.25%	160.36%	-21.43%	-190.69%	108.28%	-56.49%
Invested Capital Q/Q Growth	0.80%	4.26%	3.23%	1.43%	-6.09%	0.23%	-2.18%	2.18%	2.83%	-2.64%	10.31%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	54.00%	57.18%	51.98%	52.73%	1.70%	53.52%	54.70%	48.65%	53.71%	58.66%	59.68%
EBITDA Margin	31.61%	30.05%	18.29%	27.12%	-49.79%	35.58%	27.27%	25.67%	28.24%	35.19%	31.68%
Operating Margin	12.45%	13.45%	-1.61%	4.31%	-88.92%	19.53%	12.07%	8.26%	15.53%	23.48%	19.92%
EBIT Margin	12.45%	13.45%	-1.61%	4.13%	-88.92%	19.53%	11.93%	8.12%	15.92%	23.74%	20.06%
Profit (Net Income) Margin	9.28%	8.82%	-6.61%	-3.76%	-114.95%	14.80%	8.97%	3.29%	10.42%	17.29%	14.51%
Tax Burden Percent	86.75%	71.70%	203.47%	-87.17%	121.96%	77.75%	77.04%	41.71%	67.97%	74.21%	73.53%
Interest Burden Percent	85.95%	91.51%	202.09%	104.43%	105.99%	97.49%	97.60%	97.04%	96.28%	98.13%	98.41%
Effective Tax Rate	13.25%	28.30%	0.00%	187.17%	0.00%	22.26%	21.83%	55.95%	28.02%	23.03%	25.22%
Return on Invested Capital (ROIC)	7.14%	7.11%	-0.70%	-2.12%	-17.48%	11.66%	7.32%	3.01%	10.06%	18.93%	14.07%
ROIC Less NNEP Spread (ROIC-NNEP)	4.01%	5.31%	-17.21%	-2.17%	91.70%	13.08%	8.77%	3.87%	11.29%	20.43%	15.76%
Return on Net Nonoperating Assets (RNNOA)	1.89%	2.68%	-4.52%	-0.02%	-10.95%	-2.23%	-1.74%	-0.98%	-4.03%	-7.22%	-2.77%
Return on Equity (ROE)	9.04%	9.79%	-5.23%	-2.14%	-28.43%	9.43%	5.59%	2.04%	6.03%	11.71%	11.30%
Cash Return on Invested Capital (CROIC)	2.93%	1.78%	-6.68%	-7.92%	2.35%	3.57%	2.29%	-1.58%	-4.28%	0.97%	2.74%
Operating Return on Assets (OROA)	5.33%	6.16%	-0.57%	1.12%	-12.91%	8.77%	5.13%	3.59%	6.72%	11.43%	10.57%
Return on Assets (ROA)	3.98%	4.04%	-2.33%	-1.02%	-16.69%	6.65%	3.86%	1.45%	4.40%	8.33%	7.65%
Return on Common Equity (ROCE)	7.15%	7.78%	-4.26%	-1.79%	-24.17%	8.04%	4.83%	1.80%	5.49%	10.68%	10.64%
Return on Equity Simple (ROE_SIMPLE)	10.92%	12.11%	-7.55%	-2.69%	-39.97%	10.69%	6.56%	2.37%	7.00%	10.36%	11.02%
Net Operating Profit after Tax (NOPAT)	38	36	-3.38	-9.57	-85	60	35	14	42	68	43
NOPAT Margin	10.80%	9.64%	-1.12%	-3.76%	-62.24%	15.18%	9.43%	3.64%	11.18%	18.07%	14.89%
Net Nonoperating Expense Percent (NNEP)	3.13%	1.80%	16.50%	0.05%	-109.18%	-1.42%	-1.44%	-0.86%	-1.23%	-1.51%	-1.68%
Return On Investment Capital (ROIC_SIMPLE)	5.91%	6.05%	-0.57%	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	46.00%	42.82%	48.02%	45.72%	98.30%	46.48%	45.30%	51.35%	46.29%	41.34%	40.32%
SG&A Expenses to Revenue	37.68%	38.52%	45.89%	46.03%	79.18%	31.20%	31.38%	28.86%	32.95%	30.86%	32.10%
R&D to Revenue	1.45%	2.70%	1.76%	2.72%	4.10%	1.32%	3.67%	5.48%	4.32%	3.41%	5.54%
Operating Expenses to Revenue	41.55%	43.74%	53.59%	49.97%	91.06%	33.98%	42.63%	40.39%	38.18%	35.18%	39.76%
Earnings before Interest and Taxes (EBIT)	44	50	-4.83	11	-122	77	45	31	60	89	58
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	111	113	55	69	-68	141	102	98	107	132	92
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.50	3.00	3.12	2.96	2.69	2.29	2.30	2.84	3.73	3.94	5.53
Price to Tangible Book Value (P/TBV)	6.38	4.43	4.62	3.59	3.23	2.62	2.68	3.28	4.26	4.42	6.70
Price to Revenue (P/Rev)	3.83	2.19	2.73	4.14	7.74	3.16	3.14	3.94	5.56	6.58	7.29
Price to Earnings (P/E)	51.75	32.37	0.00	0.00	0.00	26.72	51.53	639.54	72.88	44.04	53.28
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.93%	3.09%	0.00%	0.00%	0.00%	3.74%	1.94%	0.16%	1.37%	2.27%	1.88%
Enterprise Value to Invested Capital (EV/IC)	2.93	2.05	2.13	2.50	2.52	2.31	2.34	3.07	4.42	5.72	6.34
Enterprise Value to Revenue (EV/Rev)	4.52	2.85	3.50	4.57	8.07	3.14	3.10	3.79	5.26	5.95	7.09
Enterprise Value to EBITDA (EV/EBITDA)	14.31	9.48	19.12	16.84	0.00	8.81	11.36	14.75	18.63	16.91	22.38
Enterprise Value to EBIT (EV/EBIT)	36.32	21.20	0.00	110.60	0.00	16.05	25.95	46.61	33.04	25.07	35.34
Enterprise Value to NOPAT (EV/NOPAT)	41.87	29.57	0.00	0.00	0.00	20.65	32.83	104.07	47.07	32.92	47.59
Enterprise Value to Operating Cash Flow (EV/OCF)	22.49	18.23	60.71	191.86	0.00	13.73	10.54	16.89	25.49	26.41	23.70
Enterprise Value to Free Cash Flow (EV/FCFF)	102.04	118.11	0.00	0.00	96.61	67.35	104.85	0.00	0.00	641.10	244.64
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.70	0.73	0.80	0.53	0.66	0.03	0.06	0.04	0.04	0.04	0.01
Long-Term Debt to Equity	0.70	0.73	0.80	0.53	0.66	0.03	0.06	0.04	0.04	0.04	0.01
Financial Leverage	0.47	0.50	0.26	0.01	-0.12	-0.17	-0.20	-0.25	-0.36	-0.35	-0.18
Leverage Ratio	2.27	2.42	2.24	2.10	1.70	1.42	1.45	1.40	1.37	1.41	1.48
Compound Leverage Factor	1.95	2.22	4.53	2.19	1.81	1.38	1.41	1.36	1.32	1.38	1.45
Debt to Total Capital	41.31%	42.17%	44.37%	34.44%	39.68%	2.76%	5.93%	4.03%	4.18%	4.14%	1.09%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	41.31%	42.17%	44.37%	34.44%	39.68%	2.76%	5.93%	4.03%	4.18%	4.14%	1.09%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	12.22%	12.12%	11.20%	11.32%	9.18%	14.43%	13.69%	12.06%	9.87%	7.54%	10.18%
Common Equity to Total Capital	46.47%	45.70%	44.43%	54.24%	51.14%	82.82%	80.39%	83.91%	85.95%	88.32%	88.73%
Debt to EBITDA	2.39	2.24	4.78	3.27	-4.48	0.13	0.37	0.26	0.26	0.22	0.05
Net Debt to EBITDA	1.49	1.56	2.99	0.51	0.37	-0.76	-1.03	-1.36	-1.67	-2.19	-1.11
Long-Term Debt to EBITDA	2.39	2.24	4.78	3.27	-4.48	0.13	0.37	0.26	0.26	0.22	0.05
Debt to NOPAT	7.00	6.98	-77.73	-23.62	-3.58	0.30	1.07	1.83	0.65	0.43	0.11
Net Debt to NOPAT	4.35	4.87	-48.64	-3.69	0.30	-1.78	-2.97	-9.63	-4.21	-4.27	-2.35
Long-Term Debt to NOPAT	7.00	6.98	-77.73	-23.62	-3.58	0.30	1.07	1.83	0.65	0.43	0.11
Altman Z-Score	2.04	1.39	1.24	1.83	1.06	4.07	3.26	4.14	6.42	7.02	7.51
Noncontrolling Interest Sharing Ratio	20.89%	20.56%	18.51%	16.20%	15.00%	14.70%	13.55%	11.41%	9.04%	8.80%	5.88%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.47	1.87	2.85	3.75	2.67	2.93	2.23	1.92	2.32	2.58	1.63
Quick Ratio	1.20	1.55	2.55	3.45	2.43	2.53	1.81	1.76	2.08	2.38	1.52
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	16	9.05	-32	-36	11	18	11	-7.28	-18	3.47	8.42
Operating Cash Flow to CapEx	840.50%	903.02%	205.61%	168.94%	-3,301.43%	1,217.84%	822.65%	353.58%	509.70%	194.66%	216.70%
Free Cash Flow to Firm to Interest Expense	1.84	1.25	-4.98	-5.05	1.63	5.22	3.79	-3.75	-8.04	2.09	9.11
Operating Cash Flow to Interest Expense	8.36	8.11	2.69	0.86	-3.28	25.60	37.71	43.96	34.86	50.70	94.05
Operating Cash Flow Less CapEx to Interest Expense	7.37	7.21	1.38	0.35	-3.38	23.50	33.13	31.53	28.02	24.65	50.65
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.43	0.46	0.35	0.27	0.15	0.45	0.43	0.44	0.42	0.48	0.53
Accounts Receivable Turnover	2.89	2.75	2.44	3.06	1.76	4.10	2.12	1.59	1.74	1.88	1.61
Inventory Turnover	5.03	5.09	4.94	3.50	3.26	4.20	4.50	5.36	4.32	5.54	8.71
Fixed Asset Turnover	1.46	1.51	1.17	0.95	0.47	1.35	1.34	1.46	1.63	1.86	1.84
Accounts Payable Turnover	7.02	6.22	7.02	6.34	6.53	7.01	6.03	8.84	8.04	6.23	5.14
Days Sales Outstanding (DSO)	126.39	132.63	149.37	119.11	207.56	88.94	172.24	229.35	209.76	193.81	227.35
Days Inventory Outstanding (DIO)	72.57	71.77	73.86	104.16	111.89	86.87	81.08	68.05	84.51	65.92	41.89
Days Payable Outstanding (DPO)	52.03	58.70	52.03	57.60	55.90	52.07	60.57	41.28	45.40	58.58	70.94
Cash Conversion Cycle (CCC)	146.94	145.70	171.20	165.66	263.55	123.75	192.74	256.12	248.87	201.15	198.29
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	544	521	494	466	439	536	494	470	449	389	325
Invested Capital Turnover	0.66	0.74	0.63	0.56	0.28	0.77	0.78	0.83	0.90	1.05	0.95
Increase / (Decrease) in Invested Capital	22	27	29	26	-97	42	24	21	60	64	35
Enterprise Value (EV)	1,593	1,069	1,052	1,164	1,106	1,241	1,160	1,442	1,985	2,224	2,059
Market Capitalization	1,349	820	821	1,054	1,061	1,252	1,177	1,499	2,098	2,459	2,117
Book Value per Share	$5.68	$5.00	$4.71	$6.03	$6.69	$8.94	$8.18	$8.15	$8.41	$9.02	$5.59
Tangible Book Value per Share	$4.02	$3.39	$3.18	$4.98	$5.58	$7.80	$7.02	$7.07	$7.37	$8.03	$4.61
Total Capital	644	598	593	656	770	661	637	629	654	706	431
Total Debt	266	252	263	226	306	18	38	25	27	29	4.71
Total Long-Term Debt	266	252	263	226	306	18	38	25	27	29	4.71
Net Debt	166	176	165	35	-25	-107	-105	-133	-177	-288	-102
Capital Expenditures (CapEx)	8.43	6.49	8.42	3.59	0.70	7.42	13	24	15	43	40
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-20	43	167	162	30	148	18	61	64	36	14
Debt-free Net Working Capital (DFNWC)	81	119	264	352	347	257	160	219	269	354	120
Net Working Capital (NWC)	81	119	264	352	347	257	160	219	269	354	120
Net Nonoperating Expense (NNE)	5.35	3.07	16	0.00	72	1.51	1.72	1.33	2.86	2.94	1.10
Net Nonoperating Obligations (NNO)	166	176	165	35	-25	-107	-105	-133	-177	-288	-102
Total Depreciation and Amortization (D&A)	67	62	60	59	54	63	57	67	46	43	34
Debt-free, Cash-free Net Working Capital to Revenue	-5.61%	11.42%	55.48%	63.55%	21.85%	37.30%	4.91%	15.95%	16.90%	9.70%	4.69%
Debt-free Net Working Capital to Revenue	22.95%	31.74%	87.86%	137.98%	253.51%	64.97%	42.73%	57.64%	71.16%	94.63%	41.35%
Net Working Capital to Revenue	22.95%	31.74%	87.86%	137.98%	253.51%	64.97%	42.73%	57.64%	71.16%	94.63%	41.35%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.49	$0.47	($0.40)	($0.38)	($2.43)	$0.76	$0.36	$0.04	$0.43	$0.79	$0.58
Adjusted Weighted Average Basic Shares Outstanding	52.65M	54.31M	56.67M	58.58M	58.95M	61.36M	61.48M	64.90M	66.31M	69.69M	68.99M
Adjusted Diluted Earnings per Share	$0.48	$0.46	($0.40)	($0.38)	($2.43)	$0.76	$0.36	$0.04	$0.42	$0.78	$0.56
Adjusted Weighted Average Diluted Shares Outstanding	53.86M	55.15M	56.67M	58.58M	58.95M	61.36M	61.48M	64.90M	66.31M	69.69M	68.99M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	($0.38)	($2.43)	$0.76	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	53.02M	52.95M	53.97M	58.58M	58.95M	61.36M	61.48M	64.90M	66.31M	69.69M	68.99M
Normalized Net Operating Profit after Tax (NOPAT)	41	38	-0.25	6.45	-82	61	52	34	42	68	46
Normalized NOPAT Margin	11.73%	10.23%	-0.08%	2.53%	-59.56%	15.35%	13.88%	8.98%	11.26%	18.24%	15.80%
Pre Tax Income Margin	10.70%	12.30%	-3.25%	4.31%	-94.25%	19.04%	11.65%	7.88%	15.33%	23.30%	19.74%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.18	6.97	-0.75	1.48	-17.38	21.89	15.32	15.92	26.90	53.43	63.07
NOPAT to Interest Expense	4.49	5.00	-0.53	-1.35	-12.16	17.02	12.11	7.13	18.88	40.67	46.83
EBIT Less CapEx to Interest Expense	4.18	6.07	-2.06	0.98	-17.48	19.79	10.74	3.49	20.06	27.38	19.67
NOPAT Less CapEx to Interest Expense	3.50	4.10	-1.84	-1.86	-12.26	14.92	7.53	-5.30	12.04	14.63	3.43
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	4.35%	-13.60%	-51.05%	-2.68%	7.48%	20.64%	0.00%	0.00%	14.72%	0.00%
Augmented Payout Ratio	54.95%	85.51%	-432.01%	-301.28%	-26.91%	44.74%	233.41%	368.59%	5.08%	92.91%	7.26%

This table displays calculated financial ratios and metrics derived from IMAX's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	9.53%	7.74%	-11.98%	-9.20%	-9.00%	-12.27%	51.11%	32.46%	44.82%	-9.69%	21.47%
EBITDA Growth	16.12%	58.57%	-16.74%	-22.88%	8.96%	-24.59%	249.11%	92.15%	342.18%	-46.92%	-18.38%
EBIT Growth	39.33%	247.28%	-11.90%	-80.46%	4.90%	-63.66%	603.24%	14,107.92%	241.94%	-70.60%	-351.34%
NOPAT Growth	42.92%	26.40%	9.59%	29.45%	5.93%	23.06%	617.02%	14,894.96%	203.80%	-63.93%	-396.83%
Net Income Growth	50.37%	107.37%	2.16%	-47.23%	5.80%	-18.87%	293.62%	326.14%	142.87%	-69.50%	-22.27%
EPS Growth	-33.33%	80.00%	18.18%	-53.33%	50.00%	25.00%	237.50%	400.00%	117.39%	-76.47%	-14.29%
Operating Cash Flow Growth	163.38%	186.62%	22.71%	655.62%	-151.69%	-76.21%	397.97%	407.09%	660.88%	-34.34%	325.02%
Free Cash Flow Firm Growth	84.18%	30.13%	-279.84%	-51.15%	-390.73%	11.61%	73.82%	17.35%	74.72%	-92.48%	-376.64%
Invested Capital Growth	3.09%	4.30%	7.88%	7.43%	11.73%	5.48%	4.44%	5.50%	3.43%	6.16%	4.30%
Revenue Q/Q Growth	-6.48%	1.33%	2.80%	12.43%	-8.02%	-17.21%	6.04%	12.69%	-11.32%	42.60%	-7.05%
EBITDA Q/Q Growth	20.54%	-23.56%	57.51%	-19.99%	64.61%	-59.87%	45.90%	13.04%	13.93%	85.79%	-19.70%
EBIT Q/Q Growth	75.19%	-51.00%	602.03%	-76.88%	336.66%	-87.57%	55.73%	24.09%	51.27%	272.16%	-4,234.65%
NOPAT Q/Q Growth	12.62%	-53.32%	24.13%	119.02%	-0.40%	-59.53%	46.63%	79.23%	15.70%	270.03%	-4,096.04%
Net Income Q/Q Growth	18.70%	-55.25%	202.44%	-6.40%	63.70%	-77.95%	56.24%	87.64%	25.53%	152.61%	-82.47%
EPS Q/Q Growth	-55.56%	-65.38%	271.43%	16.67%	20.00%	-77.27%	46.67%	275.00%	0.00%	125.00%	-220.00%
Operating Cash Flow Q/Q Growth	-39.48%	-67.45%	0.70%	419.46%	-373.72%	-86.06%	520.08%	-78.15%	26.00%	191.65%	482.38%
Free Cash Flow Firm Q/Q Growth	44.13%	35.41%	3.45%	54.60%	-146.78%	-251.12%	61.58%	-47.42%	55.55%	-3.99%	-21.29%
Invested Capital Q/Q Growth	4.22%	0.80%	0.99%	-2.83%	5.44%	4.26%	0.57%	1.06%	-0.45%	3.23%	1.59%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	61.36%	52.19%	55.79%	49.38%	59.26%	51.05%	60.36%	59.08%	57.31%	57.31%	46.11%
EBITDA Margin	37.00%	28.71%	38.06%	24.84%	34.90%	19.50%	40.24%	29.24%	29.15%	22.69%	17.42%
Operating Margin	19.31%	10.26%	21.23%	3.23%	15.25%	3.18%	21.21%	14.52%	13.11%	7.69%	-6.16%
EBIT Margin	19.23%	10.26%	21.23%	3.11%	15.12%	3.18%	21.21%	14.44%	13.11%	7.69%	-6.37%
Profit (Net Income) Margin	9.40%	7.41%	16.78%	5.70%	6.85%	3.85%	14.46%	9.81%	5.89%	4.16%	-11.28%
Tax Burden Percent	52.80%	82.48%	86.59%	471.47%	51.23%	226.63%	69.62%	73.53%	51.19%	66.92%	143.41%
Interest Burden Percent	92.62%	87.51%	91.28%	38.92%	88.45%	53.34%	97.92%	92.41%	87.78%	80.91%	123.55%
Effective Tax Rate	47.20%	17.52%	13.41%	-371.47%	48.77%	-126.63%	30.38%	26.47%	48.81%	33.08%	0.00%
Return on Invested Capital (ROIC)	6.57%	5.60%	12.22%	10.56%	5.50%	5.33%	11.67%	7.75%	4.55%	3.22%	-2.86%
ROIC Less NNEP Spread (ROIC-NNEP)	6.23%	5.02%	11.29%	5.74%	5.10%	3.62%	11.44%	7.13%	3.90%	2.26%	-8.20%
Return on Net Nonoperating Assets (RNNOA)	3.46%	2.37%	4.89%	2.96%	2.86%	1.83%	4.67%	2.80%	1.15%	0.59%	-1.94%
Return on Equity (ROE)	10.03%	7.97%	17.11%	13.52%	8.37%	7.15%	16.34%	10.55%	5.69%	3.82%	-4.81%
Cash Return on Invested Capital (CROIC)	4.19%	2.93%	-0.83%	-0.76%	-4.07%	1.78%	3.17%	-2.58%	-4.26%	-6.68%	-7.67%
Operating Return on Assets (OROA)	8.27%	4.40%	8.64%	1.35%	6.74%	1.46%	9.94%	6.28%	5.14%	2.71%	-2.37%
Return on Assets (ROA)	4.05%	3.17%	6.83%	2.48%	3.06%	1.76%	6.77%	4.27%	2.31%	1.47%	-4.20%
Return on Common Equity (ROCE)	7.80%	6.30%	13.60%	10.69%	6.56%	5.68%	13.16%	8.51%	4.59%	3.11%	-3.87%
Return on Equity Simple (ROE_SIMPLE)	11.83%	0.00%	10.07%	10.79%	12.89%	0.00%	11.79%	4.09%	-1.06%	0.00%	-3.87%
Net Operating Profit after Tax (NOPAT)	8.84	7.85	17	14	6.18	6.21	15	10	5.84	5.04	-2.97
NOPAT Margin	10.20%	8.47%	18.38%	15.22%	7.81%	7.22%	14.76%	10.68%	6.71%	5.14%	-4.31%
Net Nonoperating Expense Percent (NNEP)	0.34%	0.57%	0.93%	4.82%	0.41%	1.70%	0.22%	0.62%	0.65%	0.96%	5.33%
Return On Investment Capital (ROIC_SIMPLE)	1.33%	1.22%	-	-	-	1.04%	-	-	-	0.85%	-
Cost of Revenue to Revenue	38.64%	47.77%	44.21%	50.62%	40.78%	48.95%	39.64%	40.92%	42.69%	41.87%	55.07%
SG&A Expenses to Revenue	38.61%	34.98%	34.41%	42.23%	39.50%	40.77%	34.92%	39.71%	39.28%	38.62%	47.86%
R&D to Revenue	1.52%	1.24%	-0.29%	2.28%	2.76%	3.16%	2.67%	2.82%	2.13%	1.66%	1.62%
Operating Expenses to Revenue	42.19%	41.96%	34.56%	46.15%	43.97%	47.86%	39.16%	44.56%	44.20%	50.44%	51.10%
Earnings before Interest and Taxes (EBIT)	17	9.51	19	2.77	12	2.74	22	14	11	7.54	-4.38
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	32	27	35	22	28	17	42	29	25	22	12
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.67	4.50	3.73	3.30	3.41	3.00	3.68	3.43	3.92	3.12	2.90
Price to Tangible Book Value (P/TBV)	6.60	6.38	5.34	4.92	5.16	4.43	5.28	5.04	5.82	4.62	4.18
Price to Revenue (P/Rev)	3.88	3.83	3.13	2.47	2.41	2.19	2.73	2.64	3.16	2.73	2.54
Price to Earnings (P/E)	55.64	51.75	46.38	41.26	33.76	32.37	41.53	207.72	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.80%	1.93%	2.16%	2.42%	2.96%	3.09%	2.41%	0.48%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.94	2.93	2.47	2.15	2.14	2.05	2.54	2.32	2.57	2.13	2.08
Enterprise Value to Revenue (EV/Rev)	4.63	4.52	3.85	3.21	3.20	2.85	3.28	3.28	3.85	3.50	3.20
Enterprise Value to EBITDA (EV/EBITDA)	14.38	14.31	13.11	10.59	10.21	9.48	10.74	13.05	16.93	19.12	13.36
Enterprise Value to EBIT (EV/EBIT)	34.30	36.32	35.87	28.95	22.99	21.20	22.98	39.90	86.53	0.00	75.22
Enterprise Value to NOPAT (EV/NOPAT)	41.19	41.87	37.95	34.84	32.17	29.57	34.47	85.75	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	18.75	22.49	21.00	20.23	44.42	18.23	17.75	23.81	29.85	60.71	38.18
Enterprise Value to Free Cash Flow (EV/FCFF)	71.07	102.04	0.00	0.00	0.00	118.11	81.77	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.73	0.70	0.75	0.82	0.89	0.73	0.71	0.76	0.77	0.80	0.68
Long-Term Debt to Equity	0.73	0.70	0.75	0.82	0.89	0.73	0.71	0.76	0.77	0.80	0.68
Financial Leverage	0.56	0.47	0.43	0.52	0.56	0.50	0.41	0.39	0.29	0.26	0.24
Leverage Ratio	2.33	2.27	2.34	2.41	2.47	2.42	2.37	2.32	2.24	2.24	2.20
Compound Leverage Factor	2.16	1.99	2.14	0.94	2.18	1.29	2.33	2.15	1.96	1.81	2.72
Debt to Total Capital	42.12%	41.31%	42.90%	45.20%	47.15%	42.17%	41.39%	43.13%	43.65%	44.37%	40.41%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	42.12%	41.31%	42.90%	45.20%	47.15%	42.17%	41.39%	43.13%	43.65%	44.37%	40.41%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	12.77%	12.22%	12.16%	12.11%	11.82%	12.12%	11.54%	11.27%	11.79%	11.20%	11.39%
Common Equity to Total Capital	45.11%	46.47%	44.94%	42.69%	41.02%	45.70%	47.07%	45.60%	44.57%	44.43%	48.20%
Debt to EBITDA	2.42	2.39	2.72	2.61	2.59	2.24	2.14	2.90	3.47	4.78	3.07
Net Debt to EBITDA	1.58	1.49	1.69	1.76	1.88	1.56	1.21	1.81	2.12	2.99	1.89
Long-Term Debt to EBITDA	2.42	2.39	2.72	2.61	2.59	2.24	2.14	2.90	3.47	4.78	3.07
Debt to NOPAT	6.92	7.00	7.88	8.57	8.15	6.98	6.86	19.02	-60.51	-77.73	-14.15
Net Debt to NOPAT	4.52	4.35	4.90	5.80	5.93	4.87	3.88	11.87	-37.04	-48.64	-8.70
Long-Term Debt to NOPAT	6.92	7.00	7.88	8.57	8.15	6.98	6.86	19.02	-60.51	-77.73	-14.15
Altman Z-Score	2.05	1.91	1.48	1.15	1.47	1.19	1.66	1.54	1.50	1.29	1.27
Noncontrolling Interest Sharing Ratio	22.21%	20.89%	20.51%	20.96%	21.64%	20.56%	19.41%	19.29%	19.34%	18.51%	19.54%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.25	1.47	1.41	1.39	3.31	1.87	1.88	2.81	1.90	2.85	2.72
Quick Ratio	1.86	1.20	1.15	1.13	2.90	1.55	1.63	2.46	1.66	2.55	2.37
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-8.15	-15	-23	-23	-52	-21	-5.95	-15	-11	-24	-23
Operating Cash Flow to CapEx	422.55%	249.02%	3,133.39%	2,209.21%	-993.48%	101.44%	1,876.83%	718.91%	5,829.12%	530.23%	249.52%
Free Cash Flow to Firm to Interest Expense	-4.53	-7.70	-9.62	-10.25	-26.49	-10.27	-3.81	-8.62	-5.69	-13.11	-17.17
Operating Cash Flow to Interest Expense	3.86	6.06	15.02	15.35	-5.64	1.97	18.43	2.58	11.51	9.35	4.36
Operating Cash Flow Less CapEx to Interest Expense	2.95	3.63	14.54	14.66	-6.21	0.03	17.45	2.22	11.31	7.58	2.62
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.43	0.43	0.41	0.44	0.45	0.46	0.47	0.43	0.39	0.35	0.37
Accounts Receivable Turnover	2.74	2.89	2.76	2.90	2.78	2.75	2.96	2.83	2.80	2.44	2.99
Inventory Turnover	4.81	5.03	3.91	4.34	4.29	5.09	4.11	4.66	4.77	4.94	3.99
Fixed Asset Turnover	1.48	1.46	1.43	1.50	1.50	1.51	1.58	1.43	1.29	1.17	1.22
Accounts Payable Turnover	7.46	7.02	5.09	7.37	7.09	6.22	5.57	7.49	7.03	7.02	7.80
Days Sales Outstanding (DSO)	133.38	126.39	132.12	126.06	131.26	132.63	123.43	128.79	130.23	149.37	122.17
Days Inventory Outstanding (DIO)	75.88	72.57	93.47	84.19	85.16	71.77	88.81	78.37	76.51	73.86	91.48
Days Payable Outstanding (DPO)	48.96	52.03	71.77	49.50	51.48	58.70	65.52	48.70	51.94	52.03	46.82
Cash Conversion Cycle (CCC)	160.30	146.94	153.81	160.75	164.94	145.70	146.72	158.46	154.81	171.20	166.83
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	567	544	540	534	550	521	500	497	492	494	479
Invested Capital Turnover	0.64	0.66	0.66	0.69	0.70	0.74	0.79	0.73	0.68	0.63	0.66
Increase / (Decrease) in Invested Capital	17	22	39	37	58	27	21	26	16	29	20
Enterprise Value (EV)	1,664	1,593	1,331	1,150	1,174	1,069	1,268	1,154	1,263	1,052	998
Market Capitalization	1,397	1,349	1,080	882	883	820	1,055	927	1,035	821	792
Book Value per Share	$5.65	$5.68	$5.49	$5.08	$4.93	$5.00	$5.26	$4.96	$4.89	$4.71	$4.87
Tangible Book Value per Share	$3.99	$4.02	$3.84	$3.41	$3.26	$3.39	$3.66	$3.37	$3.30	$3.18	$3.38
Total Capital	664	644	644	626	631	598	610	594	592	593	567
Total Debt	280	266	276	283	297	252	252	256	259	263	229
Total Long-Term Debt	280	266	276	283	297	252	252	256	259	263	229
Net Debt	183	166	172	191	216	176	143	160	158	165	141
Capital Expenditures (CapEx)	1.65	4.61	1.13	1.59	1.10	3.95	1.53	0.65	0.36	3.18	2.31
Debt-free, Cash-free Net Working Capital (DFCFNWC)	50	-20	-26	-18	195	43	92	160	93	167	156
Debt-free Net Working Capital (DFNWC)	147	81	79	74	276	119	201	255	193	264	243
Net Working Capital (NWC)	147	81	79	74	276	119	201	255	193	264	243
Net Nonoperating Expense (NNE)	0.69	0.98	1.47	8.47	0.76	2.90	0.32	0.85	0.71	0.96	4.79
Net Nonoperating Obligations (NNO)	183	166	172	191	216	176	143	160	158	165	141
Total Depreciation and Amortization (D&A)	15	17	15	19	16	14	20	15	14	15	16
Debt-free, Cash-free Net Working Capital to Revenue	13.99%	-5.61%	-7.48%	-5.01%	53.21%	11.42%	23.74%	45.52%	28.47%	55.48%	50.13%
Debt-free Net Working Capital to Revenue	40.97%	22.95%	22.76%	20.56%	75.28%	31.74%	52.07%	72.60%	58.75%	87.86%	78.13%
Net Working Capital to Revenue	40.97%	22.95%	22.76%	20.56%	75.28%	31.74%	52.07%	72.60%	58.75%	87.86%	78.13%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.04	$0.10	$0.26	$0.07	$0.06	$0.05	$0.22	$0.15	$0.05	$0.04	($0.16)
Adjusted Weighted Average Basic Shares Outstanding	53.15M	52.65M	52.68M	52.63M	52.50M	54.31M	54.62M	54.59M	54.06M	56.67M	55.97M
Adjusted Diluted Earnings per Share	$0.04	$0.09	$0.26	$0.07	$0.06	$0.05	$0.22	$0.15	$0.04	$0.04	($0.16)
Adjusted Weighted Average Diluted Shares Outstanding	54.97M	53.86M	54.09M	53.43M	53.41M	55.15M	55.54M	55.32M	54.99M	56.67M	55.97M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	53.74M	53.02M	52.68M	52.68M	52.62M	52.95M	54.61M	54.62M	54.59M	53.97M	55.97M
Normalized Net Operating Profit after Tax (NOPAT)	8.87	11	17	2.01	6.18	3.03	15	10	6.53	5.04	-2.97
Normalized NOPAT Margin	10.23%	11.80%	18.38%	2.26%	7.81%	3.53%	14.76%	10.68%	7.51%	5.14%	-4.31%
Pre Tax Income Margin	17.81%	8.98%	19.38%	1.21%	13.37%	1.70%	20.77%	13.34%	11.51%	6.22%	-7.87%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	9.25	5.02	8.26	1.21	6.15	1.35	14.12	7.88	6.18	4.18	-3.31
NOPAT to Interest Expense	4.91	4.14	7.16	5.93	3.18	3.05	9.83	5.83	3.16	2.80	-2.24
EBIT Less CapEx to Interest Expense	8.34	2.59	7.78	0.52	5.58	-0.60	13.14	7.52	5.99	2.42	-5.06
NOPAT Less CapEx to Interest Expense	3.99	1.71	6.68	5.24	2.61	1.11	8.85	5.47	2.97	1.04	-3.99
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	4.35%	4.26%	37.45%	0.00%	-13.60%	-24.23%
Augmented Payout Ratio	0.32%	54.95%	139.56%	142.00%	123.00%	85.51%	95.30%	362.76%	-2,806.95%	-432.01%	-695.02%

Frequently Asked Questions About IMAX's Financials

When does IMAX's financial year end?

According to the most recent income statement we have on file, IMAX's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has IMAX's net income changed over the last 10 years?

IMAX's net income appears to be on a downward trend, with a most recent value of $32.70 million in 2024, falling from $42.17 million in 2014. The previous period was $33.07 million in 2023. View IMAX's forecast to see where analysts expect IMAX to go next.

What is IMAX's operating income?

IMAX's total operating income in 2024 was $43.86 million, based on the following breakdown:

Total Gross Profit: $190.20 million
Total Operating Expenses: $146.34 million

How has IMAX revenue changed over the last 10 years?

Over the last 10 years, IMAX's total revenue changed from $290.54 million in 2014 to $352.21 million in 2024, a change of 21.2%.

How much debt does IMAX have?

IMAX's total liabilities were at $452.18 million at the end of 2024, a 3.6% decrease from 2023, and a 132.1% increase since 2014.

How much cash does IMAX have?

In the past 10 years, IMAX's cash and equivalents has ranged from $76.20 million in 2023 to $317.45 million in 2015, and is currently $100.59 million as of their latest financial filing in 2024.

How has IMAX's book value per share changed over the last 10 years?

Over the last 10 years, IMAX's book value per share changed from 5.59 in 2014 to 5.68 in 2024, a change of 1.8%.

Related Companies

This page (NYSE:IMAX) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IMAX (IMAX) Financials

Frequently Asked Questions About IMAX's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IMAX (IMAX) Financials

Annual Income Statements for IMAX

Quarterly Income Statements for IMAX

Annual Cash Flow Statements for IMAX

Quarterly Cash Flow Statements for IMAX

Annual Balance Sheets for IMAX

Quarterly Balance Sheets for IMAX

Annual Metrics And Ratios for IMAX

Quarterly Metrics And Ratios for IMAX

Frequently Asked Questions About IMAX's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools